schestowitz@joindiaspora.com
Dr. Roy Schestowitz

The language here suggests the author is clueless; #EPO and #USPTO don't care about patent quality; EPO became like USPTO, only caring about money, nothing else https://www.lexology.com/commentary/intellectual-property/thailand/mirandah-asia/thailand-rejects-covid-19-drug-granted-by-european-patent-office-and-us-patent-and-trademark-office see http://techrights.org/2021/03/25/epo-potential-improvements/

Thailand rejects covid-19 drug granted by European Patent Office and US Patent and Trademark Office

Favipiravir is a broad-spectrum antiviral drug used in the treatment of multiple diseases and is the first drug that has been approved by various countries as an emergency treatment for covid-19. Thailand's Department of Intellectual Property has...

There are no comments yet.